Delivery Order SPE2DB22D2006-SPE2DB25FW1HK
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count) valued at $6,601.92. This non-competitive, firm fixed-price delivery order was issued on July 29, 2025, with an ultimate completion date of July 30, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This award represents a routine pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,541.94 to AmerisourceBergen Drug Corp for the supply of Concerta ER 27 mg tablets (100-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by December 30, 2025. The order was placed on December 29, 2025, and will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,846.16 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100 count) on September 29, 2025, with completion targeted for September 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The order represents a child contract action under AmerisourceBergen's broader...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Concerta ER 54 mg tablets (100-count units) with a ceiling value of $9,482.11. This competitively awarded, non-set-aside delivery order was issued on December 16, 2025, with an ultimate completion date of December 17, 2025, and is structured under a firm fixed-price contract type. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $3,301.25 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 36 mg, with an ultimate completion date of July 25, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Concerta ER 27 mg tablets (100-count) with a ceiling value of $1,801.16. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 9, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's primary hub for pharmaceutical...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $50,513.86 on September 19, 2025, for the supply of Concerta ER 54 mg tablets (100 count). The contract is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was made through competitive procurement with no set-aside designation. This delivery...
- The Defense Logistics Agency (DLA) awarded a $5,978.22 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 18 mg on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Concerta ER 54 mg tablets (100-count units) with a contract ceiling value of $17,614.54. This firm fixed-price delivery order, which is set to be completed by November 14, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 27 mg with a ceiling value of $1,910.48 under a firm fixed-price contract. The award, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a non-competitive delivery against an existing contract vehicle. Performance will be executed from the contractor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW1HKDelivery Order
The Defense Logistics Agency (DLA) awarded a $79,589.84 delivery order to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count units) under a firm fixed-price contract. The award, issued on May 30, 2025, with an ultimate completion date of June 2, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform this delivery order from its corporate office location in Conshohocken, PA 19428. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999 and extends through December 2026. This comprehensive IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs and other federal healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard. The firm's position as a critical pharmaceutical distributor in the federal medical supply chain reflects its capability to fulfill competitive federal procurement requirements across multiple therapeutic domains and delivery scales.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $79.6k | 5/30/25 |